Machine Learning for Medical Applications

Name: Machine Learning for Medical Applications | Computational Drug Discovery, Bioimaging, Smart Biomaterials
Brand: De Gruyter
Price: 169.95 EUR
Availability: OnlineOnly

Computational Drug Discovery, Bioimaging, Smart Biomaterials

Ranjith Rajamanickam Amit Sharma Dhivya Ranjith J. Paulo Davim(Editor)

De Gruyter (Publisher)

1st Edition

Published on 1. September 2025

X, 540 pages

E-Book

PDF with digital watermarking

System requirements

978-3-11-150320-2 (ISBN)

€169.95incl. 7% vat

System requirements

for PDF with digital watermarking

E-Book Single Licence

Available for download

Description

More details

Other editions

Persons

Content

Intro
Contents
List of contributors
Blockchain technology to secure medical data sharing in machine learning applications ensure privacy and integrity
1 Introduction
2 EHR management systems
2.1 Fundamentals of blockchain-based EHR systems
2.2 EHR
2.3 Overview of traditional EHR management systems
2.4 Evolution of blockchain-based EHR solutions
2.5 Key milestones in the evolution of blockchain-based EHR solutions
2.6 Key components and architecture of blockchain-based EHR systems
3 Security and privacy in blockchain-based EHR systems
3.1 Importance of security and privacy in healthcare data
3.2 Security challenges in traditional EHR systems
3.3 Enhancement of blockchain security in EHR management
3.4 Privacy-preserving techniques in blockchain-based EHRs
3.5 Compliance with healthcare regulations (e.g., GDPR, HIPAA)
4 Interoperability and data sharing in blockchain-based EHR systems
4.1 Interoperability challenges in healthcare data exchange
4.2 Role of blockchain in enabling interoperability
4.3 Standards and protocols for interoperable EHR systems
4.4 Blockchain-based solutions for seamless data sharing
4.5 Case studies of successful interoperable EHR implementations
5 Smart contracts for access control and governance
5.1 Introduction to smart contracts in blockchain technology
5.2 Application of smart contracts in healthcare
5.3 Role-based access control (RBAC) in EHR management
5.4 Implementing fine-grained access control with smart contracts
5.5 Governance models for blockchain-based EHR systems
6 Data integrity and auditability in blockchain-based EHR systems
6.1 Importance of data integrity in healthcare data management
6.2 Challenges in ensuring data integrity in traditional EHRs
6.3 Ensuring blockchain data integrity and immutability
6.4 Auditing and traceability features of blockchain-based EHR systems
6.5 Real-world examples of data integrity assurance in blockchain EHRs
7 Conclusion
References
AI-powered sensors and devices for sustained health tracking
1 Introduction
2 Overview of biomedical sensors and devices
2.1 Types of biomedical sensors and devices
2.2 Implantable sensors
2.3 Remote monitoring systems
2.4 Diagnostic and imaging sensors
2.5 Therapeutic devices
3 Functionality and applications
3.1 Vital signs monitoring
3.2 Chronic disease management
3.3 Preventive and predictive health
3.4 Data acquisition and analysis
3.5 User interaction and feedback
4 Technological advancements
4.1 Miniaturization and wearability
4.2 Connectivity and communication
4.3 Materials and manufacturing
4.4 Enhanced sensor capabilities
4.5 Regulatory and compliance advances
5 Challenges and limitations
5.1 Accuracy and reliability
5.2 Data privacy and security
5.3 User acceptance and compliance
5.4 Cost and accessibility
5.5 Technical and operational issues
6 Future directions
6.1 Emerging technologies
6.2 Personalized and precision health
6.3 Interdisciplinary research and collaboration
6.4 Global health and accessibility
6.5 Regulatory and ethical considerations
7 Conclusion
References
Development of AI-driven biomedical sensors and devices optimization for continuous health monitoring
1 Introduction
2 Overview of biomedical sensors
2.1 Definition and purpose of biomedical sensors
2.2 Historical development and milestones
2.3 Types of biomedical sensors
2.3.1 Electrochemical sensors
2.3.2 Optical sensors
2.3.3 Temperature sensors
2.3.4 Pressure sensors
2.3.5 Bioelectrical sensors
2.4 Key components and technologies
2.4.1 Sensing elements
2.4.2 Signal transduction mechanisms
2.4.3 Power supply and energy management
2.4.4 Data processing and communication
2.4.5 Interface and user interaction
2.5 Importance in modern healthcare
3 Evolution and advancements in sensor technology
3.1 Early biomedical sensors: limitations and challenges
3.2 Advances in materials science
3.3 Miniaturization and nanotechnology
3.4 Wireless and wearable sensor technologies
3.5 Integration with mobile health (mHealth) applications
4 Importance of AI in continuous health monitoring
4.1 Role of AI in data processing and analysis
4.2 Enhancing accuracy and precision of sensors
4.3 Real-time health monitoring and alerts
4.4 Predictive analytics for early disease detection
4.5 Personalization of health monitoring and treatment
5 Key AI technologies used in biomedical sensors
5.1 Machine learning algorithms
5.2 Deep learning and neural networks
5.3 Signal processing techniques
5.3.1 Noise reduction and filtering
5.3.2 Signal denoising techniques
5.3.3 Feature extraction and selection
5.3.4 Data fusion and multisensory integration
5.3.5 Real-time signal processing
5.4 Data fusion and multisensor integration
5.5 Edge computing and AI at the sensor level
6 Case studies and applications
6.1 AI-enhanced wearable health monitors
6.2 Implantable sensors for chronic disease management
6.3 Remote patient monitoring systems
6.4 AI in telehealth and telemedicine
6.5 Success stories and clinical trials
7 Conclusion
References
Design and development of AI-driven biomedical sensors and devices and their optimization for continuous health monitoring
1 Introduction
2 Introduction to biomedical sensors
2.1 Definition and classification of biomedical sensors
2.2 Historical evolution of biomedical sensors
2.3 Key functionalities of biomedical sensors in health monitoring
2.3.1 Real-time data acquisition and monitoring of data
2.3.2 Wearable and implantable device compatibility
2.3.3 Transmission of data and material and person-to-person interaction
2.3.4 Personalization and adaptation
2.3.5 Early warning system and predictive modeling
2.3.6 Navigation and alert interfaces
2.4 Role of sensors in preventive healthcare
2.5 Current market trends and innovations in biomedical sensors
2.5.1 Emergence of wearable sensors
2.5.2 Combination of AI and ML
2.5.3 Multimodal and hybrid sensors, and their development
2.5.4 New techniques and technologies of noncontact and telemetric recording
3 Types of biomedical sensors
3.1 Wearable sensors for continuous monitoring
3.2 Implantable sensors for internal monitoring
3.3 Noninvasive sensors
3.3.1 Optical sensors
3.3.2 Electrochemical sensors
3.3.3 Acoustic sensors
3.3.4 Bioimpedance sensors
3.3.5 Thermal sensors
3.4 Biosensors
3.5 Optical, chemical, and mechanical sensors
4 Technological advancements in sensor design
4.1 Flexible and stretchable electronics in biomedical sensors
4.1.1 Flexible and stretchable electronics: An overview
4.1.2 Advantages of flexible electronics in biomedical application of sensors
4.1.3 Uses of flexible electronics for biomedical sensors
4.1.4 The future of challenges
4.2 Nanotechnology-enhanced sensors for high sensitivity
4.2.1 Quantum dots in biosensing
4.2.2 Carbon nanotube and graphene in sensors
4.2.3 Nano coatings for high performance
4.2.4 Afflation of combining nanotechnology with microfluidics
4.2.5 Novelty in nanotechnology: nanostructured sensing platforms
4.3 Microelectromechanical systems (MEMS) in biomedical applications
4.3.1 Overview of MEMS technology
4.3.2 MEMS sensors used in physiological monitoring
4.4 Advances in wireless and battery-free sensor technologies
4.4.1 Wireless communication technologies
4.4.2 Battery-less sensor technologies
4.5 Hybrid and multimodal sensor systems for comprehensive monitoring
4.5.1 Multiplexed multiple sensing
4.5.2 Patient compliance and comfort can be easily enhanced
4.5.3 Data fusion by applying ensemble learning and data mining
4.5.4 Some applications in personalized and preventive medicine
5 Biomedical sensors in chronic disease management
5.1 Sensors for cardiovascular health monitoring
5.1.1 ECG sensors
5.1.2 Blood pressure sensors
5.1.3 Pulse oximeters
5.1.4 Heart rate variability (HRV) sensors
5.2 Glucose monitoring sensors for diabetes management
5.2.1 General information on glucose monitoring devices
5.2.2 The expectations to improvements in glucose sensors via technology
5.2.3 Compatibility with insulin delivery systems
5.2.4 Issues and innovations
5.3 Respiratory monitoring sensors for pulmonary diseases
5.3.1 Uses in managing diseases
5.3.2 Challenges and considerations
5.4 Neurological monitoring
5.4.1 EEG sensors
5.4.2 ICP monitors
5.4.3 Brain-computer interface (BCI)
5.4.4 Portable electrical stimulation apparatus
5.4.5 Intelligent prostheses and adaptive neuroprosthetics
5.5 Long-term monitoring solutions for geriatric care
5.5.1 Wearable health monitoring devices
5.5.2 Remote health monitoring systems
5.5.3 Wearable sensors for internal recording
5.5.4 Integrated health monitoring systems
5.5.5 Fall-risk identification and mitigation systems
5.5.6 Challenges and considerations
6 Challenges in biomedical sensor development
6.1 Sensor accuracy and calibration issues
6.1.1 Role of precision on biomedical sensors
6.1.2 Calibration procedures
6.1.3 Sources of accuracy issues
6.1.4 The main challenges in calibration techniques
6.1.5 Modern technologies related to calibration
6.2 Power consumption and energy harvesting solutions
6.2.1 Power consumption challenges
6.2.2 Low-power design techniques
6.2.3 Energy harvesting with integration of sensors
6.2.4 New battery technologies
6.2.5 Hybrid power solutions
6.2.6 Annotated bibliography of future directions and research
6.3 Data privacy and security in sensor networks
6.3.1 Protecting health information that can be identified
6.3.2 Protection of the communication media
6.3.3 Overcoming some of the concerns over privacy with wearable devices
6.3.4 Maintaining the directory of information files
6.3.5 Acceptance of compliance with regulatory standards
6.3.6 Security threats and responding to vulnerabilities
6.3.7 Security versus ease of use
6.4 Wearability and patient compliance
6.4.1 Environmental comfort and design implications
6.4.2 Durability and longevity
6.4.3 Ease of use and integration
6.4.4 Beauty and customization
6.4.5 Effects of psychological and patient involvement
6.4.6 Barriers to wearability
6.4.7 Data privacy and security
6.5 Scalability and cost-effectiveness of sensor technologies
6.5.1 Manufacturing scalability
6.5.2 Materials used and availability
6.5.3 Economies of scale
6.5.4 Areas of integration and system-level cost aspects
6.5.5 Market presentation and price-setting directions
7 Conclusion
References
Machine learning-driven personalized medicine: customized drug delivery systems and patient-specific material applications
1 Introduction
2 Historical background and evolution of personalized medicine
2.1 Origins of personalized medicine
2.2 Milestones in the development of personalized healthcare
2.3 Evolution of treatment approaches
2.3.1 Multiplatform and personalized medicine
2.3.2 Evolution of possible ways of treatment
2.4 Key figures and contributions in the history of personalized medicine
2.4.1 Sir Francis Crick and James D. Watson
2.4.2 Linus Pauling
2.4.3 Baruch S. Blumberg and Robert L. Wilner
2.4.4 Leroy Hood
2.4.5 Eric Lander
2.4.6 Francis Collins
2.4.7 George Church
2.4.8 James P. Allison, Elon Musk, and Steve Jobs
2.5 The impact of genomic research on personalized treatment strategies
3 Fundamental concepts of personalized medicine
3.1 Defining personalized medicine
3.2 The role of genetics and genomics in personalized treatment
3.3 Understanding the patient's genetic, environmental, and lifestyle influences
3.3.1 Genetic influences
3.3.2 Environmental influences
3.3.3 Lifestyle influences
3.3.4 Integration of factors
3.4 Differences between precision medicine and personalized medicine
3.5 The interplay between personalized medicine and conventional healthcare approaches
4 Technological advancements enabling personalized medicine
4.1 The role of next-generation sequencing in personalized healthcare
4.2 Integration of Big Data and artificial intelligence in personalized medicine
4.3 Innovations in biomarker discovery and their impact on treatment customization
4.4 Role of CRISPR and gene editing technologies in tailoring therapies
4.5 The contribution of bioinformatics and computational tools to personalized medicine
5 Clinical applications of personalized medicine
5.1 Personalized approaches in oncology
5.2 Role of personalized medicine in managing cardiovascular diseases
5.3 Customizing treatment strategies for neurological disorders
5.4 Applications of personalized medicine in rare and genetic diseases
5.5 The impact of personalized medicine on preventive healthcare and early diagnosis
6 Challenges and barriers in implementing personalized medicine
6.1 Ethical and privacy concerns in the era of personalized healthcare
6.2 Regulatory challenges in approving personalized therapies
6.3 Cost and accessibility
6.4 Technical challenges
6.5 Addressing disparities in access to personalized medicine across different populations
7 Conclusion
References
Personalized medicine using customized drug delivery systems and patient-specific material solutions, enabled by machine learning algorithms
1 Introduction
2 Historical evolution of personalized medicine
2.1 Early developments in personalized medicine
2.2 The role of genomics in shaping modern personalized medicine
2.2.1 Newer methods of genomic sequencing
2.2.2 Discovery of gene signatures and diseases links
2.2.3 New frontiers in the use of genomic profiling for targeted therapy
2.2.4 Application of genomics, in conjunction with other omics platforms
2.2.5 Ethical and practical implication of genomic medicine
2.3 Key milestones and breakthroughs in personalized treatments
2.4 Influence of technological advancements on personalized approaches
2.4.1 Technologies in genomic sequencing
2.4.2 Bioinformatics about computational biology
2.4.3 Diagnostic innovations
2.4.4 Artificial intelligent and advanced computing
2.4.5 API integration with digital health platforms
2.5 Case studies illustrating the historical shifts in personalized medicine
2.5.1 New development in the fields of molecular diagnostics in rare genetic disorders
2.5.2 The rise of pharmacogenomics
2.5.3 Treatment strategies in specific cancers
3 Core concepts and definitions
3.1 Defining personalized medicine
3.2 Differentiating personalized medicine from traditional medicine
3.2.1 Treatment and treatment plan/philosophy
3.2.2 Role of genetic information
3.2.3 Diagnosis and risk assessment
3.2.4 Therapeutic methods and techniques
3.2.5 Monitoring and adaptation
3.3 Essential components of personalized treatment plans
3.3.1 S10Molecular and genetic characterization
3.3.2 Individual therapy models
3.3.3 Dynamic treatment adjustments
3.3.4 Main provisions of the interdisciplinary approach
3.3.5 Patient and caregiver involvement
3.3.6 Ethical and privacy issues
3.4 The role of patient data in personalizing healthcare
3.4.1 Genomic data and the influence on personalized medicine
3.4.2 Clinical data and its part in decision-making
3.4.3 Phenotype data and intervention personalization
3.4.4 Lifestyle and environmental variables in personalization
3.4.5 Data integration and advance analytics
3.5 Integrative approaches: combining genomics, proteomics, and metabolomics
3.5.1 Metabolomics: Profiling metabolic pathways
3.5.2 Systems interoperability and technology solutions: applications and future directions
4 Technological advancements driving personalized medicine
4.1 Advances in genomic sequencing technologies
4.1.1 Next-generation sequencing
4.1.2 Whole-genome sequencing (WGS)
4.1.3 Whole-exome sequencing (WES)
4.1.4 Advanced single-cell sequencing technologies
4.2 The impact of bioinformatics and computational biology
4.2.1 DMI
4.2.2 Graphics design, logistic regression modeling, and risk analysis
4.2.3 Systems biology and network analysis
4.2.4 Future prospects and issues
4.3 Innovations in diagnostic technologies for personalized medicine
4.3.1 NGS technologies
4.3.2 Liquid biopsy techniques
4.3.3 Discovery of biomarkers: Steps one and two
4.3.4 Digital health and wearable technologies
4.4 The role of artificial intelligence and machine learning
4.4.1 Enhancing diagnostic accuracy
4.4.1.1 Treatments based on clients' individual characteristics
4.4.2 Drug development optimization
4.4.3 Integration with omics data
4.5 Emerging tools and technologies enhancing personalized care
4.5.1 Next-generation sequencing
4.5.2 Next-generation proteomics platforms
4.5.3 Artificial intelligence and machine learning algorithms
4.5.4 Smart clothing and personalized health solutions
4.5.5 CRISPR and other gene editing technologies
4.5.6 Advanced imaging techniques
5 Benefits and impact on healthcare outcomes
5.1 Improved diagnostic accuracy and early detection
5.1.1 Greater accuracy when identifying the disease
5.1.2 Screening of other silent compensated diseases
5.1.3 Factors contributing to high risk for pathogens
5.1.4 Enhanced diagnostic precision due to the inclusion of multi-omics data
5.1.5 Supplementary surveillance of disease status
5.1.6 Enabling specific client management
5.2 Tailoring treatment plans to individual genetic profiles
5.2.1 Higher accuracy of diseases differentiation
5.2.2 Improved treatment efficacy
5.2.3 Individual preventive interventions
5.2.4 Patient participation and compliance
5.3 Enhancing drug efficacy and reducing adverse drug reactions
5.3.1 Pharmacokinetics, drug therapy, and dosage regimen individualization
5.3.2 Molecular and individualized treatment
5.3.3 Screening and assessment of biomarkers
5.3.4 Enhancing patients compliance and health outcomes
5.4 Personalized medicine's role in chronic disease management
5.4.1 Tailored treatment plans
5.4.2 The development in disease surveillance and control
5.4.3 Patient engagement and thus medication adherence
5.4.4 Minimization of the adverse drug reaction
5.4.5 Inspiring resource management
5.5 Economic and quality-of-life benefits of personalized approaches
5.5.1 Minimization of adverse drug reactions and healthcare costs as well
5.5.2 Improved treatment effectiveness and result
5.5.3 Screening and early interference
5.5.4 Better outpatients' involvement and satisfaction
5.5.5 Economic consequences and healthcare system resilience: current and future
6 Current trends and future directions
6.1 The rise of precision oncology and targeted therapies
6.1.1 Clinical development of specific anticancer agents
6.1.2 Biomarkers into the strategies
6.1.3 Emergence of immunotherapy
6.1.4 Future paths and trends
6.2 Advances in personalized medicine for rare and genetic diseases
6.2.1 Genetic counseling and risk assessment: new developments
6.2.2 Application of multiplatform analysis
6.2.3 Introduction of digital health resources and telemedicine
6.2.4 Gene therapy and personalized interventions for the future
6.3 Integration of personalized medicine with digital health platforms
6.3.1 Real-time data collection for monitoring
6.3.2 Personalization with linked data
6.3.3 Remote consultations and telemedicine
6.3.4 Big data analytics and statistical analysis
6.3.5 The achievement of interoperability with electronic health record systems
6.3.6 Prediction and transformation
6.4 Trends in personalized medicine research and clinical trials
6.4.1 The integration of multi-omics data
6.4.2 Molecular/precision medicine/genetics: oncology
6.4.3 Patient-centric clinical trial designs
6.4.3.1 Fostering of real-world evidence (RWE)
6.4.4 Advance and recent adoption of digital health technologies
6.4.4.1 Focus on Underserved Populations Typically Managed by Limited Local Practitioners
6.4.4.2 Emerging trends in therapy
6.5 Future prospects
6.5.1 New trends in artificial intelligence and machine learning
6.5.2 Potential of precision oncology
6.5.2.1 Personalized medicine in rare and genetic diseases
6.5.3 Links with digital health and wearables
6.5.4 Subsidiary of KPMG International Cooperative "KPMG" to pay US$20 million for work related to ethical and regulatory developments
6.5.5 Global partnership and information exchange
6.5.5.1 The future of personalized medicine: global cooperation of researchers, clinicians, and institutions for better data sharing
7 Conclusion
References
AI-driven drug design exploring molecular docking and lead optimization using machine learning algorithms
1 Introduction
2 Applications of AI in target identification and validation
2.1 Predictive modeling for target selection
2.2 Network analysis for identifying disease-relevant pathways
2.3 AI-Driven prediction of protein-protein interactions
2.4 Genomic data analysis for target prioritization
2.5 AI-based identification of novel drug targets from omics data
3 Machine learning techniques in hit identification
3.1 High-throughput virtual screening using ML algorithms
3.2 QSAR modeling for predicting compound activity
3.3 Deep learning approaches for compound similarity search
3.4 Ensemble learning methods in hit identification
3.5 Feature engineering for improving hit identification models
4 AI Applications in molecular docking and binding affinity prediction
4.1 Deep learning models for protein-ligand binding prediction
4.2 Structure-based virtual screening using ML algorithms
4.3 Molecular dynamics simulations guided by AI
4.4 Machine learning approaches for predicting binding free energies
4.5 Reinforcement learning in molecular docking optimization
5 AI-driven lead optimization strategies
5.1 Generative models for de novo drug design
5.2 Multi-objective optimization in lead optimization
5.3 AI-based structure-activity relationship (SAR) analysis
5.4 Cheminformatics approaches for lead optimization
5.5 Machine learning models for ADMET prediction in lead optimization
6 Integrating AI with experimental methods in preclinical testing
6.1 AI-driven analysis of high-throughput screening data
6.2 Predictive modeling for toxicity assessment
6.3 AI-based biomarker discovery in preclinical studies
6.4 Integration of AI with phenotypic screening platforms
6.5 Machine learning approaches for predicting in vivo efficacy
7 Conclusion
References
Machine learning models for predicting drug toxicity and side effects
1 Introduction
2 Supervised learning techniques
2.1 Linear models
2.2 Decision trees
2.3 Random forests
2.4 Support vector machines (SVM)
2.5 Neural networks
3 Unsupervised learning techniques
3.1 Clustering algorithms
3.2 Dimensionality reduction
3.3 Anomaly detection
3.4 Association rule learning
3.5 Autoencoders
4 Ensemble learning methods
4.1 Bagging
4.2 Boosting
4.3 Stacking
4.4 Voting classifiers
4.5 Hybrid models
5 Evaluation and validation techniques
5.1 Cross-validation
5.2 Performance metrics
5.3 Hyperparameter tuning
5.4 Model robustness and stability
5.5 External validation
6 Advanced topics and future directions
6.1 Deep learning architectures
6.2 Transfer learning and domain adaptation
6.3 Explainable AI and model interpretability
6.4 Interaction with computational chemistry
6.5 Ethical and regulatory considerations
7 Conclusion
References
Machine learning innovations in biomedical materials from drug discovery to personalized medicine
1 Introduction
2 Introduction to machine learning in biomedical materials
2.1 Historical overview of biomedical materials development
2.2 The emergence of machine learning in material science
2.3 Key differences between traditional and ML-driven approaches
2.4 Importance of data in biomedical material science
2.5 Challenges in adopting machine learning for material development
3 Machine learning algorithms for biomedical materials
3.1 Overview of supervised learning techniques in material science
3.1.1 Regression techniques
3.1.2 Classification techniques
3.1.3 Neural networks
3.1.4 Ensemble methods
3.1.5 Support vector machines (SVMs)
3.2 Unsupervised learning for clustering and classifying materials
3.2.1 Clustering techniques
3.2.2 Data visualization
3.2.3 Applying the concept of material discovery and optimization
3.3 Applications of deep learning in biomedical materials
3.3.1 Design of drug delivery systems
3.3.2 The use of images in the determination of material characteristics
3.3.3 Improvement of methods used in preparing materials
3.3.4 Bordering on personalized biomedical materials
3.3.5 Improving material degradability
3.4 Reinforcement learning for material property optimization
3.5 Transfer learning in the context of biomedical materials
4 Data acquisition and preprocessing in biomedical material science
4.1 Types of data in biomedical materials
4.1.1 Genomic data
4.1.2 Proteomic data
4.1.3 Metabolomic data
4.1.4 Material property data
4.1.5 Biological interaction data
4.1.6 Clinical data
4.2 Data cleaning and preprocessing techniques
4.2.1 Handling missing data
4.2.2 Data normalization and scaling
4.2.3 Feature engineering and selection
4.2.4 Coordination and harmonization of data
4.2.5 Outlier detection and how to handle it
4.2.6 Data integration and harmonization
4.2.7 Outlier detection and handling
4.2.8 Data transformation and encoding
4.3 Handling missing data and inconsistencies
4.3.1 Causes of missing data and inconsistencies
4.3.2 Strategies for handling missing data
4.3.3 Managing inconsistencies:
4.3.4 Impact on machine learning models
4.3.5 Best practices and tools
4.4 Feature engineering and selection for material properties
4.5 Challenges in data integration from multiple sources
5 Model development and validation in biomedical materials
5.1 Building predictive models for material properties
5.1.1 Algorithm selection
5.1.2 Feature definition and engineering
5.1.3 Model training
5.1.4 Model validation and evaluation
5.1.5 Model interpretation and refinement
5.2 Cross-validation techniques for ensuring model robustness
5.3 Model interpretability and explainability in material science
5.4 Techniques for reducing overfitting in ML models
5.4.1 Regularization methods
5.4.2 Cross-validation
5.4.3 Early stopping
5.4.4 Data augmentation
5.4.5 Ensemble methods
5.4.6 Pruning techniques
5.5 Benchmarking and comparing ML models in biomedical materials
6 Applications of machine learning in biomedical material discovery
6.1 Predictive modeling for material biocompatibility
6.2 Machine learning in the design of drug delivery systems
6.3 Role of ML in tissue engineering and regenerative medicine
6.4 Optimizing material synthesis processes with machine learning
6.5 Case studies
6.5.1 Important considerations in the identification of new drug delivery techniques
6.5.2 The prediction of biocompatibility for biomaterials
6.5.3 Tissue engineering scaffolds optimization
6.5.4 Work to produce materials useful for the implementation of personalized medicine
6.5.5 A high-throughput screening of antibody-drug conjugate
6.5.6 Application of regenerative medicine
7 Conclusion
References
High-throughput screening for novel medical materials: machine learning-enabled approaches
1 Introduction
2 Automated prediction of material properties
2.1 Introduction to material properties crucial for drug delivery systems
2.2 Machine learning techniques for predicting material properties
2.3 Machine learning and linking to other experiment/computational method techniques
2.4 Applications of ML in optimizing material formulations
3 Optimization of drug release profiles
3.1 Introduction to drug release kinetics in delivery systems
3.2 Machine learning algorithms for the prediction of drug release profiles
3.3 Case studies of ML-enhanced drug release optimization
3.4 Personalization of drug delivery systems based on patient-specific factors
3.5 Regulatory challenges and opportunities in ML-driven drug release optimization
4 Design optimization of nanoparticle-based delivery systems
4.1 Exploration of ML algorithms for optimizing nanoparticle design parameters
4.2 Methodologies for integrating ML with experimental and computational approaches
4.3 Case studies illustrating tailored nanoparticle designs for specific therapeutic applications
4.4 Advancements in ML techniques enhancing precision in nanoparticle-based drug delivery
4.5 Future directions in advancing ML for complex nanoparticle designs
5 Personalized medicine approaches in drug delivery
5.1 ML-driven strategies for customizing drug delivery based on patient-specific data
5.2 Adaptive dosing regimens and targeted delivery strategies enabled by ML
5.3 Applications of ML in personalized medicine and patient outcomes
5.4 Ethical considerations and regulatory implications in personalized drug delivery
5.5 Future trends in ML applications for personalized drug delivery
6 Challenges and opportunities in implementing ML in drug delivery optimization
6.1 Current challenges in adopting ML-driven approaches in drug delivery
6.2 Regulatory considerations and compliance with safety and efficacy standards
6.3 Opportunities for integrating ML with real-time data analytics in clinical settings
6.4 Future directions in leveraging ML to enhance drug delivery efficiency
6.5 Recommendations for overcoming barriers and advancing ML in biomedical research
7 Conclusion
References
Automated materials characterization using machine learning for screening biocompatible materials
1 Introduction
2 Definition and importance of biocompatible materials
2.1 Defining biocompatibility
2.2 The role of biocompatible materials in modern medicine
2.3 Historical evolution of biocompatible materials
2.4 Key properties that determine biocompatibility
2.5 The impact of biocompatible materials on patient outcomes
3 Classification of biocompatible materials
3.1 Metals as biocompatible materials
3.2 Ceramics in biomedical applications
3.3 Polymers for biocompatibility
3.3.1 Natural polymers
3.3.2 Synthetic polymers
3.3.3 Bioactive polymers
3.3.4 Biodegradable polymers
3.3.5 Challenges and innovations
3.4 Composite materials
3.4.1 Pattern of biological activities and convergent concatenability
3.4.2 Customization and versatility
3.4.3 Biomedical engineering applications
3.5 Emerging biocompatible materials
3.5.1 Nanomaterials
3.5.2 Bioresorbable polymers
3.5.3 Smart materials
3.5.4 Conductive polymers
3.5.5 Biodegradable composites
4 Applications of biocompatible materials
4.1 Implants and prosthetics
4.1.1 Orthopedic implants
4.1.2 Dental implants
4.1.3 Cardiovascular implants
4.1.4 Prosthetic limbs
4.1.5 Cochlear implants
4.2 Drug delivery systems
4.2.1 Controlled-release formulations
4.2.2 Targeted drug delivery
4.2.3 Smart drug delivery technologies
4.2.4 Biodegradable implants for drug delivery
4.2.5 Injectable drug delivery systems
4.3 Tissue engineering
4.3.1 Scaffold design and function
4.3.2 Bioprinting and advanced fabrication techniques
4.3.3 Cell-seeding and growth factors
4.3.4 Applications in regenerative medicine
4.3.5 Challenges and future directions
4.4 Biocompatible coatings
4.4.1 Drug-eluting coatings
4.4.2 Antimicrobial coatings
4.4.3 Surface modification coatings
4.4.4 Hydrophobic and hydrophilic coatings
4.4.5 Bioactive coatings
4.5 Wearable devices
4.5.1 Continuous health monitoring
4.5.2 Biocompatible materials for enhanced comfort
4.5.3 Integration with digital health systems
4.5.4 Therapeutic wearables
4.5.5 Wearable sensors for chronic disease management
5 Factors influencing biocompatibility
5.1 Chemical composition and its impact on biocompatibility
5.1.1 Material composition and biological interaction
5.1.2 Surface chemistry and protein adsorption
5.1.3 Degradation products and cytotoxicity
5.1.4 Interaction with biological fluids
5.1.5 Long-term stability and chemical durability
5.2 Surface properties
5.2.1 Surface chemistry
5.2.2 Surface topography
5.2.3 Surface roughness
5.2.4 Wettability
5.2.5 Surface stability and degradation
5.3 Mechanical properties
5.3.1 Strength and durability
5.3.2 Flexibility and compliance
5.3.3 Hardness and surface properties
5.3.4 Fatigue resistance
5.3.5 Creep and deformation
5.4 Degradation and stability
5.4.1 Material degradation mechanisms
5.4.2 Rate of degradation
5.4.3 Stability in biological environments
5.4.4 Impact of degradation products
5.4.5 Long-term stability and performance
5.5 Interaction with the immune system
5.5.1 Immune response to foreign materials
5.5.2 Surface properties and immune activation
5.5.3 Material degradation and immune response
5.5.4 Immune system modulation and biocompatibility
5.5.5 Personalized approaches to immune compatibility
6 Challenges in the development of biocompatible materials
6.1 Predicting long-term biocompatibility
6.1.1 Material degradation and longevity
6.1.2 Long-term biological reactions
6.1.3 Variability in patient responses
6.1.4 Incomplete simulation of in vivo conditions
6.1.5 Regulatory and ethical considerations
6.2 Balancing biocompatibility with functionality
6.2.1 Trade-offs between biocompatibility and mechanical properties
6.2.2 Functionalization vs. biological response
6.2.3 Integration with biological tissues
6.2.4 Durability vs. biodegradability
6.2.5 Regulatory and safety considerations
6.3 The complexity of biological environments
6.3.1 Variability in biological conditions
6.3.2 Interaction with biological fluids
6.3.3 Immune system dynamics
6.3.4 Cellular and tissue integration
6.3.5 Long-term stability and degradation
6.4 Regulatory hurdles in approving new biocompatible materials
6.4.1 Comprehensive preclinical testing requirements
6.4.2 Challenges in predicting long-term biocompatibility
6.4.3 Variability in global regulatory standards
6.4.4 Post-market surveillance and reporting obligations
6.4.5 Ethical and legal considerations
6.4.6 Safety and long-term effects
6.4.7 Informed consent and patient autonomy
6.4.8 Equity and access to advanced materials
6.4.9 Environmental impact and sustainability
6.4.10 Regulatory and ethical oversight
7 Conclusion
References
Machine learning algorithms for enhanced medical image analysis and diagnostics
1 Introduction
2 Historical background of medical image processing
2.1 Early techniques in medical imaging
2.2 Evolution of image processing methods
2.3 Milestones in medical imaging technologies
2.4 Transition from analog to digital imaging
2.5 Impact of computational advances on image processing
3 Basics of machine learning
3.1 Definition and key concepts of machine learning
3.2 Types of machine learning: supervised, unsupervised, reinforcement learning
3.3 Machine learning workflow: data collection, preprocessing, model training, evaluation
3.4 Common algorithms: linear regression, decision trees, k-NN, SVM
3.5 Introduction to neural networks and deep learning
4 Machine learning in the context of medical imaging
4.1 Why machine learning is suited for medical imaging
4.2 Comparison with traditional image processing techniques
4.3 Advantages of machine learning in handling medical images
4.4 Overview of machine learning applications in medical imaging
4.5 Key challenges in applying machine learning to medical images
5 Key components of machine learning systems for medical imaging
5.1 Data acquisition and labeling
5.2 Image preprocessing techniques: normalization, augmentation, noise reduction
5.3 Feature extraction methods: manual vs. automated
5.4 Model selection and training: classical algorithms vs. deep learning models
5.5 Performance evaluation metrics: accuracy, sensitivity, specificity, ROC-AUC
6 Common machine learning techniques in medical image processing
6.1 CNNs: architecture and applications
6.2 RNNs and LSTM networks
6.3 GANs for image enhancement and synthesis
6.4 Transfer learning and pretrained models in medical imaging
6.5 Ensemble methods and hybrid models
7 Conclusion
References
Transforming healthcare with machine learning
1 Introduction
2 Deep learning techniques in biomedical materials
2.1 Convolutional neural networks (CNNs) for material property prediction
2.2 Recurrent neural networks (RNNs) in time-series analysis of material behavior
2.2.1 RNNs' employment in material behavior analysis
2.2.2 Substituting and improving RNN architectures for materials science
2.3 Autoencoders for dimensionality reduction in material characterization
2.3.1 Benefits and advantages
2.3.2 Challenges and considerations
2.4 Generative adversarial networks (GANs) for synthetic material data generation
2.4.1 A case study on usage of GANs in materials science
2.4.2 Four benefits of using GANs for synthetic data
2.4.3 Challenges and considerations
2.5 Transfer learning for improving material design models
2.5.1 Possibilities of transfer in material design
2.5.2 Approaches for applying transfer learning
2.5.3 Challenges and considerations
3 Ensemble methods and hybrid approaches
3.1 Random forests for classification and regression in material science
3.1.1 Mechanism of random forests
3.1.2 Appreciations in material science
3.1.3 Advantages and limitations
3.2 Gradient boosting machines (GBM) for enhancing predictive accuracy
3.2.1 Australian institutional investment: GBM mechanism and functionality
3.2.2 Real-world use of GBM for material design and discovery
3.2.3 Pros and cons of GBM
3.3 Stacking and blending techniques for integrating multiple ML models
3.3.1 Stacking: integrated models: a layered view
3.3.2 Blending: an adaptive ensemble strategy
3.3.3 Pros and cons of stacking and blending
3.4 Voting mechanisms for robust material property predictions
3.4.1 Voting schemes and its uses
3.4.2 Implementation strategies of voting mechanisms
3.4.3 Voting mechanisms: opportunities and challenges with a focus on voting optimization
3.5 Hybrid ML models combining supervised and unsupervised learning
3.5.1 Approaches toward using supervised learning and unsupervised learning
3.5.2 Major issues that hinder hybrid model development
4 Three Bayesian methods and probabilistic modeling
4.1 Bayesian optimization for hyperparameter tuning in material models
4.1.1 Application related to material science
4.1.2 Challenges and considerations
4.2 Gaussian processes for predictive modeling of material properties
4.2.1 App in material property prediction
4.2.2 Methodological framework
4.2.3 Challenges and considerations
4.3 Markov chain Monte Carlo (MCMC) techniques in material design
4.3.1 Uses of MCMC in material design
4.3.2 Procedures for the use of MCMC algorithms
4.3.3 Difficulties and implications of MCMC
4.4 Bayesian networks for understanding complex material interactions
4.4.1 Usefulness in simulating material interactions
4.4.2 Problems that occur when applying Bayesian networks to material science
4.5 Uncertainty quantification and decision-making using Bayesian methods
4.5.1 Methods of uncertainty estimation: Bayesian framework
4.5.2 Decision-making under conditions of uncertainty
4.5.3 Advantages and disadvantages in applying Bayesian method
5 Reinforcement learning and adaptive models
5.1 Reinforcement learning for adaptive material design strategies
5.1.1 The use of RL in adaptive material design
5.1.2 Strategies for enacting reinforcement learning in material design
5.1.3 Difficulties and problems in RL-based material design
5.2 Q-learning and deep Q-networks for optimizing material processes
5.2.1 Q-learning: basics and applications
5.2.2 Deep Q-networks: improving Q-learning with deep learning
5.2.3 Challenges and considerations
5.3 Policy gradient methods for dynamic material property adjustments
5.3.1 Using policy gradient methods in materials science
5.3.2 Strategies for the application of policy gradient techniques
5.3.3 Challenges and considerations
5.4 Multiagent reinforcement learning for collaborative material discovery
5.4.1 Case studies of applying the MARL concept in material discovery
5.4.2 Strategies for the application of MARL in materials science
5.5 Real-time feedback systems in material characterization using RL
5.5.1 Use and benefits in material characterization
5.5.2 Challenges and considerations
6 Explainable AI and interpretability in materials science
6.1 Feature importance and sensitivity analysis in material models
6.1.1 Methods used in measuring feature importance
6.1.2 Handling sensitivity analyses in material models
6.1.3 Applications and advantages in materials science
6.1.4 Challenges and considerations
6.2 SHAP (Shapley additive explanations) values for interpreting model predictions
6.2.1 Mechanisms of SHAP values
6.2.2 Challenges and considerations
6.3 LIME (local interpretable model-agnostic explanations) for understanding material models
6.3.1 Mechanism of LIME
6.3.2 Use and application of LIME in material models
6.3.3 Benefits of using LIME
6.3.4 Challenges and limitations
6.4 Visualization techniques for model insights in biomedical materials
6.4.1 Display of the model's actions and decisions
6.4.2 Challenges in visualizing more biomedical materials
6.5 Addressing interpretability challenges in deep learning models for materials science
6.5.1 Methods for improving the interpretable nature
6.5.2 Trade-offs and limitations
7 Conclusion
References
Revolutionizing healthcare
1 Introduction
2 Data-driven approaches in biomaterials design
2.1 High-throughput data collection for biomaterials
2.2 Big data analytics for predictive modeling
2.3 Feature selection and dimensionality reduction
2.3.1 Techniques for feature selection in biomaterials
2.3.2 Some of the difficulties in feature selection and dimensionality reduction
2.3.3 Essays on uses and examples in biomaterials
2.4 Dataset augmentation for machine learning models
2.4.1 Methods for expanding datasets
2.4.2 Challenges in dataset augmentation for biomaterials
2.4.3 Impact of dataset augmentation on model performance
2.5 Benchmark datasets for machine learning in biomaterials
2.5.1 Standardization of benchmark data sets of biomaterials
2.5.2 The use of open-source datasets to advance biomaterials science
3 Machine learning models for biomaterial property prediction
3.1 Supervised learning for predicting biomaterial properties
3.1.1 Functionality of biomaterials classification algorithms
3.1.2 Case studies: supervised learning in biomaterial design
3.1.3 Evaluating supervised models for predictive accuracy
3.1.4 Challenges in applying supervised learning to biomaterials
3.2 Unsupervised learning for biomaterial pattern recognition
3.2.1 Clustering techniques for biomaterial classification
3.2.2 Dimensionality reduction in biomaterial data analysis
3.2.3 Unsupervised feature extraction for novel biomaterials design
3.2.4 Application of anomaly detection in biomaterial quality control
3.3 Deep learning for advanced biomaterial design
3.3.1 Autoencoders for biomaterial property optimization
3.3.2 Applications of deep generative models for biomaterial discovery
3.3.3 Application of recurrent neural networks in time-series biomaterial data
3.3.4 Transfer learning in biomedical research
3.4 Ensemble learning techniques for robust prediction
3.4.1 Boosting and bagging in biomaterial property prediction
3.4.2 Stacking models for enhanced predictive performance
3.4.3 Hybrid approaches combining ML algorithms for biomaterials
3.5 Model interpretability and explainability
3.5.1 Techniques for explaining machine learning predictions
3.5.2 Ensuring transparency in AI-driven biomaterial design
4 Optimization of biomaterial properties using machine learning
4.1 Multiobjective optimization in biomaterial design
4.1.1 Pareto optimization in biomaterial research
4.1.2 A genetic algorithm approach to multiobjective biomaterial design
4.1.3 Prospects for multiobjective optimization for biomaterials
4.1.4 Case studies of optimized biomaterial properties
4.2 Reinforcement learning for adaptive biomaterial design
4.2.1 Training RL agents to optimize biomaterial properties
4.2.2 Case studies: reinforcement learning in biomaterial engineering
4.2.3 Challenges in implementing reinforcement learning (RL) for biomaterials
4.3 Bayesian optimization for efficient material search
4.3.1 Application of Bayesian methods in biomaterial discovery
4.3.2 Case studies: Bayesian optimization in biomaterial property tuning
4.3.3 Applications of Bayesian optimization with other methods
4.4 Evolutionary algorithms for biomaterial design
4.4.1 Application of genetic programming for biomaterial property optimization
4.4.2 Integrating evolutionary algorithms into machine learning
4.4.3 Case studies: evolutionary approaches in biomaterial engineering
4.5 Hyperparameter tuning for ML models in biomaterials
4.5.1 Techniques for hyperparameter tuning
4.5.2 Challenges in hyperparameter optimization for biomaterials
4.5.3 Evaluation metrics for hyperparameter tuning
5 Machine learning in the fabrication and characterization of biomaterials
5.1 Predictive modeling for additive manufacturing of biomaterials
5.1.1 Methods and strategies of predictive analytics
5.1.2 Accommodation of experimental data into machine learning currents
5.1.3 The issue in applying the various concepts of new structural dynamics for predictive modeling of additive manufacturing
5.2 Machine learning in biomaterial surface characterization
5.2.1 A coupling approach of machine learning with surface characterization methods
5.2.1 Enhancing resolution and accuracy through machine learning
5.2.2 Applications in biomaterials surface modification and optimization
5.2.3 Current issues and trend analysis of machine learning in surface characterization
5.3 ML-driven techniques for mechanical property prediction
5.3.1 Regression models in mechanical properties prediction
5.3.2 Neural networks toward enhanced mechanical property prediction
5.3.3 Integrating multimodal data for enhanced prediction accuracy
5.4 Real-time monitoring and control in biomaterial fabrication
5.4.1 Methods of real-time data gathering
5.4.2 Uncertainty in combining machine learning into manufacturing process enhancements
5.4.3 Issues related to the deployment of RTMS
5.5 Integration of ML with characterization techniques
5.5.1 Methods for improving data analysis based on machine learning
5.5.2 Forecast analysis and property enhancement
5.5.3 Real-time data integration and analysis
6 Ethical considerations and future directions
6.1 Ethical implications of AI in biomaterial design
6.1.1 Addressing bias and fairness
6.1.2 Privacy and data security protection
6.2 Challenges in data privacy and security
6.2.1 Information security needs to be safeguarded in biomaterials research
6.2.2 Data break-ins and cybersecurity risks
6.2.3 Preserving the equity between the possibility of accessing data and the need to protect it
6.3 Addressing the challenges of model generalization
6.3.1 Challenges in achieving effective generalization
6.3.2 Strategies for improving model generalization
6.3.3 Addressing data quality and representativeness
6.4 Bridging the gap between theory and practice
6.4.1 Ensuring reproducibility and scalability
6.4.2 Ethical issues: their application in the resolution of real-life problems
6.5 Future trends in machine learning for biomaterials
6.5.1 Integration of multimodal data
6.5.2 Enhanced interpretability and explainability
6.5.3 Real-time data processing and feedback
7 Conclusion
References
Index
De Gruyter Series in Advanced Mechanical Engineering
Already published in the series

System requirements

Save as PDF Copy link into clipboard

Schweitzer Fachinformationen

Machine Learning for Medical Applications

Description

More details

Other editions

Additional editions

Persons

Content

System requirements